首页> 外文OA文献 >Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohort
【2h】

Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohort

机译:评估相对于南非队列中测量的表型的预测性CYp2C19基因分型测定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM : To align predicted and measured CYP2C19 phenotype in a South African cohort.MATERIALS AND METHODS : Genotyping of CYP2C19*2, *3, *9, *15, *17, *27 and *28 wasperformed using PCR-RFLP, and an Activity Score (AS) system was used to predict phenotype.True phenotype was measured using plasma concentrations of omeprazole and its metabolite5’-hydroxyomperazole. RESULTS : Partial genotype-phenotype discrepancies were reported, and anadapted AS system was developed, which showed a marked improvement in phenotypeprediction. Results highlight the need for a more comprehensive CYP2C19 genotyping approachto improve prediction of omeprazole metabolism. CONCLUSION : Evidence for the utility of aCYP2C19 AS system is provided, for which the accuracy can be further improved by means ofcomprehensive genotyping and substrate specific modification.
机译:目的:在一个南非队列中对预测和测量的CYP2C19表型进行比对。材料与方法:使用PCR-RFLP对CYP2C19 * 2,* 3,* 9,* 15,* 17,* 27和* 28进行基因分型。使用活动评分(AS)系统预测表型。使用奥美拉唑及其代谢物5'-羟基哌唑的血浆浓度测量真实的表型。结果:报道了部分基因型-表型差异,并开发了适应性AS系统,显示出明显的表型预测改善。结果强调需要更全面的CYP2C19基因分型方法来改善奥美拉唑代谢的预测。结论:提供了aCYP2C19 AS系统实用性的证据,通过全面的基因分型和底物特异性修饰可以进一步提高准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号